1832 Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.45M | Buy |
265,437
+1,067
| +0.4% | +$28.4K | 0.01% | 391 |
|
|
2025
Q4 | $6.58M | Buy |
264,370
+69,732
| +36% | +$1.76M | 0.01% | 408 |
|
|
2025
Q3 | $4.96M | Sell |
194,638
-6,937
| -3% | -$171K | ﹤0.01% | 375 |
|
|
2025
Q2 | $4.89M | Sell |
201,575
-612,706
| -75% | -$14.3M | ﹤0.01% | 375 |
|
|
2025
Q1 | $20.6M | Sell |
814,281
-9,955,299
| -92% | -$261M | 0.02% | 279 |
|
|
2024
Q4 | $286M | Buy |
10,769,580
+5,410,759
| +101% | +$147M | 0.24% | 49 |
|
|
2024
Q3 | $155M | Buy |
5,358,821
+2,860,935
| +115% | +$83.5M | 0.12% | 93 |
|
|
2024
Q2 | $69.9M | Buy |
2,497,886
+2,487,919
| +24,962% | +$68.5M | 0.06% | 158 |
|
|
2024
Q1 | $277K | Sell |
9,967
-97,752
| -91% | -$2.71M | ﹤0.01% | 626 |
|
|
2023
Q4 | $3.1M | Sell |
107,719
-4,569,372
| -98% | -$138M | ﹤0.01% | 424 |
|
|
2023
Q3 | $155M | Buy |
4,677,091
+2,146,269
| +85% | +$75.9M | 0.22% | 78 |
|
|
2023
Q2 | $92.8M | Buy |
2,530,822
+745,976
| +42% | +$29M | 0.11% | 112 |
|
|
2023
Q1 | $72.8M | Sell |
1,784,846
-63,974
| -3% | -$2.76M | 0.11% | 141 |
|
|
2022
Q4 | $94.7M | Sell |
1,848,820
-49,717
| -3% | -$2.38M | 0.16% | 118 |
|
|
2022
Q3 | $83.1M | Buy |
1,898,537
+335,386
| +21% | +$16.3M | 0.15% | 131 |
|
|
2022
Q2 | $82M | Sell |
1,563,151
-3,784,557
| -71% | -$193M | 0.14% | 133 |
|
|
2022
Q1 | $273M | Sell |
5,347,708
-2,676,438
| -33% | -$139M | 0.39% | 61 |
|
|
2021
Q4 | $472M | Sell |
8,024,146
-580,934
| -7% | -$28.8M | 0.83% | 34 |
|
|
2021
Q3 | $376M | Sell |
8,605,080
-1,481,599
| -15% | -$65.6M | 0.71% | 45 |
|
|
2021
Q2 | $394M | Sell |
10,086,679
-34,075
| -0.3% | -$1.33M | 0.76% | 40 |
|
|
2021
Q1 | $367M | Buy |
10,120,754
+432,270
| +4% | +$15.3M | 0.79% | 37 |
|
|
2020
Q4 | $357M | Sell |
9,688,484
-746,307
| -7% | -$27.4M | 0.84% | 34 |
|
|
2020
Q3 | $361M | Sell |
10,434,791
-1,674,658
| -14% | -$58.7M | 0.94% | 27 |
|
|
2020
Q2 | $378M | Sell |
12,109,449
-149,785
| -1% | -$5.09M | 1.13% | 19 |
|
|
2020
Q1 | $382M | Buy |
12,259,234
+2,517,593
| +26% | +$85.8M | 1.38% | 17 |
|
|
2019
Q4 | $362M | Buy |
9,741,641
+155,339
| +2% | +$5.53M | 1.1% | 25 |
|
|
2019
Q3 | $329M | Buy |
9,586,302
+3,914,159
| +69% | +$142M | 1.05% | 25 |
|
|
2019
Q2 | $234M | Buy |
5,672,143
+559,068
| +11% | +$22.2M | 0.76% | 36 |
|
|
2019
Q1 | $206M | Sell |
5,113,075
-554,698
| -10% | -$22.2M | 0.7% | 39 |
|
|
2018
Q4 | $234M | Sell |
5,667,773
-1,329,019
| -19% | -$55.2M | 0.93% | 31 |
|
|
2018
Q3 | $293M | Sell |
6,996,792
-1,477,865
| -17% | -$56.9M | 0.95% | 31 |
|
|
2018
Q2 | $292M | Buy |
8,474,657
+526,406
| +7% | +$18M | 0.99% | 32 |
|
|
2018
Q1 | $269M | Buy |
7,948,251
+263,739
| +3% | +$9.07M | 0.99% | 29 |
|
|
2017
Q4 | $263M | Sell |
7,684,512
-838,229
| -10% | -$28.6M | 0.85% | 36 |
|
|
2017
Q3 | $280M | Sell |
8,522,741
-978,453
| -10% | -$31.4M | 0.98% | 31 |
|
|
2017
Q2 | $303M | Sell |
9,501,194
-101,416
| -1% | -$3.2M | 1.37% | 16 |
|
|
2017
Q1 | $312M | Sell |
9,602,610
-10,511,950
| -52% | -$331M | 1.12% | 24 |
|
|
2016
Q4 | $649M | Buy |
20,114,560
+11,508,508
| +134% | +$351M | 1.09% | 21 |
|
|
2016
Q3 | $276M | Sell |
8,606,052
-190
| -0% | -$6.35K | 1.04% | 25 |
|
|
2016
Q2 | $289M | Buy |
8,606,242
+2,347,680
| +38% | +$74.9M | 1.12% | 23 |
|
|
2016
Q1 | $293M | Buy |
6,258,562
+1,292,511
| +26% | +$36.9M | 0.71% | 40 |
|
|
2015
Q4 | $155M | Buy |
4,966,051
+3,559,106
| +253% | +$112M | 0.67% | 41 |
|
|
2015
Q3 | $41.5M | Sell |
1,406,945
-934,010
| -40% | -$29.9M | 0.17% | 121 |
|
|
2015
Q2 | $73.7M | Buy |
2,340,955
+434,720
| +23% | +$14.2M | 0.25% | 94 |
|
|
2015
Q1 | $62.5M | Sell |
1,906,235
-863,656
| -31% | -$27.5M | 0.24% | 104 |
|
|
2014
Q4 | $81.7M | Buy |
2,769,891
+1,178,162
| +74% | +$33.8M | 0.25% | 95 |
|
|
2014
Q3 | $44.5M | Buy |
1,591,729
+6,495
| +0.4% | +$182K | 0.15% | 147 |
|
|
2014
Q2 | $44.5M | Sell |
1,585,234
-7,952,658
| -83% | -$227M | 0.14% | 158 |
|
|
2014
Q1 | $289M | Buy |
9,537,892
+565,145
| +6% | +$16.9M | 0.99% | 23 |
|
|
2013
Q4 | $261M | Buy |
8,972,747
+656,289
| +8% | +$19.1M | 1% | 25 |
|
|
2013
Q3 | $226M | Sell |
8,316,458
-988,407
| -11% | -$26.9M | 1% | 27 |
|
|
2013
Q2 | $247M | Buy |
+9,304,865
| New | +$257M | 1.08% | 24 |
|
Other funds holding PFE
VCM
VPM
1832 Asset Management's PFE Position: Q1 2026 in Review
1832 Asset Management increased its Pfizer (PFE) stake by 0.4% in Q1 2026, buying an estimated $28.4K and bringing the position to 265,437 shares worth $7.45M. The position accounts for 0.01% of the portfolio, ranked #391.
1832 Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $649M in Q4 2016. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- 1832 Asset Management held 265,437 shares of Pfizer worth $7.45M as of Q1 2026.
- 1832 Asset Management bought 1,067 Pfizer shares in Q1 2026, an estimated $28.4K.
- Pfizer made up 0.01% of 1832 Asset Management's portfolio in Q1 2026, its #391 holding.
- 1832 Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- 1832 Asset Management's Pfizer position peaked at $649M in Q4 2016.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.